NXP Semiconductors NV (NXPI) Price Index Rolls to 0.988655

NXP Semiconductors N.V. (NXPI) presently has a 6 month price index of 1.190569. The price index is calculated by dividing the current share price by …

NXP Semiconductors N.V. (NXPI) presently has a 6 month price index of 1.190569. The price index is calculated by dividing the current share price by the share price six months ago. A ratio over one indicates an increase in share price over the period. A ratio lower than one shows that the price has decreased over that time period. Looking at some alternate time periods, the 12 month price index is 0.884553 and the five year is 1.433009. Narrowing in a bit closer, the 3 month is 0.966427, and the 1 month is currently 0.988655.

As we sail into the second half of the calendar year, investors may be looking to see what has gone right and what has gone wrong so far this year. Making necessary changes to some holdings may help position investors for the next couple of quarters. Being able to cut the riskier losers and take some profits from winners may help solidify the stock portfolio. As we run through the next round of company earnings reports, investors will be keeping a close eye on the data that is reported. Investors may be looking to buy companies that continue to post beats on the earnings front, and cut ties with ones that are not hitting their marks.

Value Composite Three (VC3) is another adaptation of O’Shaughnessy’s value composite but here he combines the factors used in VC1 with buyback yield. This factor is interesting for investors who’re looking for stocks with the best value characteristics, but are indifferent to whether these companies pay a dividend.

VC3 is the combination of the following factors:

Price-to-Book

Price-to-Earnings

Price-to-Sales

EBITDA/EV

Price-to-Cash flow

Buyback Yield

As with the VC1 and VC2, companies are put into groups from 1 to 100 for each ratio and the individual scores are summed up. This total score is then put into groups again from 1 to 100. 1 is cheap, 100 is expensive.

The scorecard also displays variants of the VC3 where the score is calculated for the selected company compared to peer companies in the same industry, industry group or sector.

Please note that we use Book-to-Market instead of P/B since it allows a more accurate sorting compared to P/B. Stocks with a high B/M show up at the top of the list, stocks with negative B/M are at the bottom of the list. For the same reason we use Earnings-to-Price instead of Price-to-Earnings and Cash flow-to-price instead instead of Price-to-cash flow.

Also important is that we always make sure that companies with the same score get added to the same percentile. For stock universes where the number of stocks is less than 100, we make sure that the stocks are still allocated to percentiles from 0 to 100 instead of 0 to the total number of stocks. This is particularly relevant for the industry, industry group or sector variants where if additional filters are used, the number of stocks often drops below 100.

NXP Semiconductors N.V. (NXPI) has a VC3 of 13.

Free Cash Flow Growth (FCF Growth) is the free cash flow of the current year minus the free cash flow from the previous year, divided by last year’s free cash flow. The FCF Yield of NXP Semiconductors N.V. (NXPI) is 0.106422. Free cash flow (FCF) is the cash produced by the company minus capital expenditure. This cash is what a company uses to meet its financial obligations, such as making payments on debt or to pay out dividends. The 5 Year FCF Yield of NXP Semiconductors N.V. (NXPI) is 0.059881. Experts say the higher the value, the better, as it means that the free cash flow is high, or the variability of free cash flow is low or both.

Gross Margin

Robert Novy-Marx, a professor at the university of Rochester, discovered that gross profitability – a quality factor – has as much power predicting stock returns as traditional value metrics. He found that while other quality measures had some predictive power, especially on small caps and in conjunction with value measures, gross profitability generates significant excess returns as a stand alone strategy, especially on large cap stocks.

Market watchers may also be following some quality ratios for NXP Semiconductors N.V. (NXPI). Robert Novy-Marx, a professor at the university of Rochester, discovered that gross profitability – a quality factor – has as much power predicting stock returns as traditional value metrics. He found that while other quality measures had some predictive power, especially on small caps and in conjunction with value measures, gross profitability generates significant excess returns as a stand alone strategy, especially on large cap stocks.The Gross profitability for (NXPI) is 0.230021.

Altman Z

NXP Semiconductors N.V. (NXPI) currently has an Altman Z score of 2.777821. The Z-Score for predicting bankruptcy was published in 1968 by Edward I. Altman, who was assistant professor of finance at New York University at that time. It measures the financial health of a company based on a set of income and balance sheet values. The Altman Z-Score predicts the probability that a firm will go bankrupt within 2 years. In its initial test, the Altman Z-Score was found to be 72% accurate in predicting bankruptcy two years before the event. In a series of subsequent tests, the model was found to be approximately 80%–90% accurate in predicting bankruptcy one year before the event.

At the time of writing, NXP Semiconductors N.V. (NXPI) has a Piotroski F-Score of 6. The F-Score may help discover companies with strengthening balance sheets. The score may also be used to spot the weak performers. Joseph Piotroski developed the F-Score which employs nine different variables based on the company financial statement. A single point is assigned to each test that a stock passes. Typically, a stock scoring an 8 or 9 would be seen as strong. On the other end, a stock with a score from 0-2 would be viewed as weak.

Investors may be trying to get a read on the next big stock market move. Projecting which stocks are ready to make a run can be tricky. Many investors will track the market from various angles in order to make the best educated decisions. Keeping tabs on all the important economic indicators can help when analyzing the overall health of the stock market. Some financial strategists may be projecting a sharp downturn over the next few months while others believe that there is no tangible reason for the market to lose the near-term momentum.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Insider Selling: AtriCure Inc. (NASDAQ:ATRC) SVP Sells 10000 Shares of Stock

Quantum Capital Management increased its stake in shares of AtriCure by 0.7% during the 1st quarter. Quantum Capital Management now owns …

AtriCure logoAtriCure Inc. (NASDAQ:ATRC) SVP Justin J. Noznesky sold 10,000 shares of the stock in a transaction on Monday, June 17th. The shares were sold at an average price of $30.00, for a total value of $300,000.00. Following the completion of the sale, the senior vice president now owns 94,068 shares of the company’s stock, valued at $2,822,040. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

NASDAQ ATRC traded down $0.76 during trading hours on Friday, hitting $31.38. The company’s stock had a trading volume of 151,864 shares, compared to its average volume of 220,718. AtriCure Inc. has a 52 week low of $26.11 and a 52 week high of $36.49. The stock has a market capitalization of $1.23 billion, a P/E ratio of -33.38 and a beta of 0.27. The company has a debt-to-equity ratio of 0.19, a current ratio of 4.37 and a quick ratio of 3.69. The company’s 50-day moving average price is $30.11.

AtriCure (NASDAQ:ATRC) last announced its quarterly earnings results on Thursday, April 25th. The medical device company reported ($0.20) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.24) by $0.04. The business had revenue of $53.97 million for the quarter, compared to analysts’ expectations of $52.45 million. AtriCure had a negative net margin of 7.98% and a negative return on equity of 14.35%. The firm’s revenue for the quarter was up 14.9% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.31) EPS. On average, research analysts anticipate that AtriCure Inc. will post -0.74 EPS for the current fiscal year.

A number of large investors have recently bought and sold shares of the business. Macquarie Group Ltd. increased its stake in AtriCure by 1.0% in the 4th quarter. Macquarie Group Ltd. now owns 65,786 shares of the medical device company’s stock valued at $2,013,000 after buying an additional 681 shares during the last quarter. Quantum Capital Management increased its stake in shares of AtriCure by 0.7% during the 1st quarter. Quantum Capital Management now owns 127,035 shares of the medical device company’s stock worth $3,403,000 after purchasing an additional 845 shares during the last quarter. Bell Rock Capital LLC purchased a new stake in shares of AtriCure during the 1st quarter worth approximately $26,000. Rhumbline Advisers increased its stake in shares of AtriCure by 3.4% during the 1st quarter. Rhumbline Advisers now owns 48,738 shares of the medical device company’s stock worth $1,306,000 after purchasing an additional 1,594 shares during the last quarter. Finally, Legal & General Group Plc increased its stake in shares of AtriCure by 31.0% during the 4th quarter. Legal & General Group Plc now owns 6,958 shares of the medical device company’s stock worth $213,000 after purchasing an additional 1,646 shares during the last quarter. Hedge funds and other institutional investors own 89.28% of the company’s stock.

A number of analysts have commented on ATRC shares. JPMorgan Chase & Co. set a €78.00 ($90.70) price target on shares of Porsche Automobil and gave the company a “neutral” rating in a research report on Friday, April 12th. BTIG Research started coverage on shares of GrubHub in a research report on Tuesday, April 2nd. They set a “buy” rating and a $95.00 price target on the stock. Needham & Company LLC reaffirmed a “buy” rating and set a $120.00 price target (up previously from $115.00) on shares of Synopsys in a research report on Thursday, March 28th. BidaskClub raised shares of Zynerba Pharmaceuticals from a “hold” rating to a “buy” rating in a research report on Thursday, July 4th. Finally, Zacks Investment Research cut shares of Hancock Jaffe Laboratories from a “buy” rating to a “hold” rating in a research report on Wednesday, June 26th. One investment analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $36.67.

About AtriCure

AtriCure, Inc develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems to medical centers in the United States and internationally. The company offers Isolator Synergy and Isolator Synergy Access clamps for the treatment of persistent and long-standing persistent atrial fibrillation concomitant to other open-heart surgical procedures; EPi-Sense guided coagulation system used for the coagulation of tissue; and COBRA Fusion surgical ablation system to combine bipolar temperature-controlled radio frequency energy control with monopolar energy.

Further Reading: What is the Beige Book?

Receive News & Ratings for AtriCure Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for AtriCure and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Quotient Ltd (NASDAQ:QTNT) Director Buys $27405.00 in Stock

Several hedge funds have recently added to or reduced their stakes in the business. Quantum Capital Management increased its position in shares of …

Quotient logoQuotient Ltd (NASDAQ:QTNT) Director Frederick Hallsworth acquired 3,150 shares of the company’s stock in a transaction dated Thursday, June 13th. The shares were bought at an average cost of $8.70 per share, with a total value of $27,405.00. Following the completion of the acquisition, the director now directly owns 74,398 shares in the company, valued at approximately $647,262.60. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Quotient stock traded up $0.43 during mid-day trading on Friday, hitting $10.49. The company’s stock had a trading volume of 376,184 shares, compared to its average volume of 362,449. The company has a current ratio of 4.59, a quick ratio of 3.98 and a debt-to-equity ratio of 72.27. The stock has a market cap of $669.73 million, a PE ratio of -5.46 and a beta of 0.88. The business has a 50 day moving average of $9.22. Quotient Ltd has a 12 month low of $5.52 and a 12 month high of $11.15.

Quotient (NASDAQ:QTNT) last posted its quarterly earnings results on Tuesday, May 28th. The company reported ($0.41) earnings per share for the quarter, topping the consensus estimate of ($0.44) by $0.03. The business had revenue of $8.28 million during the quarter, compared to the consensus estimate of $7.30 million. Equities analysts forecast that Quotient Ltd will post -1.59 earnings per share for the current year.

Several hedge funds have recently added to or reduced their stakes in the business. Quantum Capital Management increased its position in shares of Quotient by 0.7% in the first quarter. Quantum Capital Management now owns 388,302 shares of the company’s stock valued at $3,499,000 after acquiring an additional 2,744 shares during the period. Knott David M increased its position in shares of Quotient by 1.8% in the first quarter. Knott David M now owns 170,000 shares of the company’s stock valued at $1,532,000 after acquiring an additional 3,000 shares during the period. Lombard Odier Asset Management USA Corp increased its position in shares of Quotient by 4.0% in the first quarter. Lombard Odier Asset Management USA Corp now owns 260,000 shares of the company’s stock valued at $2,343,000 after acquiring an additional 10,000 shares during the period. Niemann Capital Management Inc. purchased a new position in shares of Quotient in the first quarter valued at about $101,000. Finally, Resources Investment Advisors Inc. purchased a new position in shares of Quotient in the first quarter valued at about $105,000. Hedge funds and other institutional investors own 63.91% of the company’s stock.

QTNT has been the subject of several recent research reports. ValuEngine raised shares of XCel Brands from a “sell” rating to a “hold” rating in a research note on Tuesday. BidaskClub raised shares of Westport Fuel Systems from a “hold” rating to a “buy” rating in a research note on Friday. Finally, Zacks Investment Research downgraded shares of Haynes International from a “hold” rating to a “sell” rating in a research note on Wednesday, May 8th.

About Quotient

Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and commercializes conventional reagent products used for blood grouping in the transfusion diagnostics market worldwide. The company is developing MosaiQ, a proprietary technology platform, which provides tests for blood grouping and serological disease screening.

Further Reading: QQQ ETF

Receive News & Ratings for Quotient Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Quotient and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Why NXP Semiconductors NV (NXPI) shares price is up 2.84% today

Today’s big question for investors is, “what’s going on with NXP Semiconductors N.V. (NASDAQ:NXPI) stock? Its price is jumping 2.67 points, trading at …

Today’s big question for investors is, “what’s going on with NXP Semiconductors N.V. (NASDAQ:NXPI) stock? Its price is jumping 2.67 points, trading at $96.79 levels, and is up 2.84% from its previous close of $94.12. The shares seem to have an active trading volume day with a reported 1743840 contracts so far this session. NXPI shares had a relatively better volume day versus average trading capacity of 4.04 million shares, but with a 0.33 billion float and a -3.64% run over a week, it’s definitely worth keeping an eye on. The one year price forecast for NXPI stock indicates that the average analyst price target is $114.89 per share. This means the stock has a potential increase of 18.7% from where the NXPI share price has been trading recently which is between $93.95 and $96.5. There are some brokerage firms that offer lower targets than the average, with one of them, even setting their price target at $95.

The shorts are climbing into NXP Semiconductors N.V. (NXPI) stock. The latest set of short interest data was released on 28 June 2019, and the numbers show a rise in short interest in NXPI shares. While short interest still represents only 2.31% of NXPI’s float, the number of shares shorted have risen by 355690. The number of shares shorted advanced to 7812186 shares, up from 7456496 shares during the preceding fortnight. With average daily trading volumes at 5294339 shares, days to cover decreased to about 2.438752 days. The most recent news story about the stock that appeared in Yahoo Finance‘s news section was titled “Dodge & Cox Boosts Stake in Microchip Technology” and dated July 12, 2019.

During the recent trading session for NXP Semiconductors N.V. (NASDAQ:NXPI), the company witnessed their stock rise $0.22 over a week and surge $2.31 from the price 20 days ago. When compared to their established 52-week high of $109.8, the high they recorded in their recent session happens to be lower. Their established 52-week high was attained by the company on 07/13/18. The recent low of $67.62 stood for a -11.85% since 12/26/18, a data which is good for most investors who are looking to take advantage of the stock’s recent rise. A beta of 1.28 is also allocated to the stock. Since the beta is greater than one, it implies that the stock is more volatile than the market, a data that traders are keeping close attention to.

Looking at the current readings for NXP Semiconductors N.V., the two-week RSI stands at 50.86. This figure suggests that NXPI stock, for now, is neutral, meaning that the shares are stable in terms of price movement. The stochastic readings, on the other hand, based on the current NXPI readings is similarly very revealing as it has a stochastic reading of 15.9% at this stage. This figure means that NXPI share price today is being overbought.

Technical chart claims that NXP Semiconductors N.V. (NXPI) would settle between $95.76/share to $97.41/share level. However, if the stock price goes below the $93.21 mark, then the market for NXP Semiconductors N.V. becomes much weaker. If that happens, the stock price might even plunge as low as $92.31 for its downside target. The stock is currently in the red zone of MACD, with the indicator reading -1.07. Traders are always alerted for the move of a stock above or below the zero line due to the fact that the reading is an indicator of the position of the short-term average relative to the long-term average. If the MACD is above the zero line, then the short-term average relative is above that of the long-term average, thus implying an upward momentum. Vice versa is the case if the MACD is below the zero line.

Analysts at Morgan Stanley raised their recommendation on shares of NXPI from Equal-Weight to Overweight in their opinion released on June 12. Stifel analysts bumped their rating on NXP Semiconductors N.V. (NASDAQ:NXPI) stock from Sell to Hold in a separate flash note issued to investors on June 05. Analysts at BofA/Merrill are sticking to their Buy stance. However, on May 01, they lifted price target for these shares to $125 from $105.

NXPI equity has an average rating of 2.18, with the figure leaning towards a bullish end. 22 analysts who tracked the company were contacted by Reuters. Amongst them, 9 rated the stock as a hold while the remaining 13 were split even though not equally. Some analysts rate the stock as a buy or a strong buy while no rated it as a sell. 13 analysts rated NXP Semiconductors N.V. (NASDAQ:NXPI) as a buy or a strong buy while not a single analyst advised that investors should desist from purchasing the stock or sell them if they already own the company’s stock.

Moving on, NXPI stock price is currently trading at 10.23X forward 12-month Consensus EPS estimates, and its P/S ratio is 3.42 while for the average stock in the same group, the multiple is 8.3. NXP Semiconductors N.V. current P/E ratio of 14.54 means it is trading at a premium against its industry’s 8.48. In the past 5 years, this ratio for the stock has been fluctuating between 10.92 and 170.35.

NXP Semiconductors N.V. (NXPI)’s current-quarter revenues are projected to climb by nearly -3.95% to hit $2.2 billion, based on current Zacks Consensus Estimate. The firm’s full-year revenues are expected to expand by over -4.35% from $9.41 billion to a noteworthy $9 billion. At the other end of the current quarter income statement, NXP Semiconductors N.V. is expected to see its adjusted earnings surge by roughly 41.6% to hit $1.77 per share. For the fiscal year, NXPI’s earnings are projected to climb by roughly 4.97% to hit $7.82 per share.

Related Posts:

  • No Related Posts

Diversified Trust Co Buys iShares Core US Aggregate Bond, NXP Semiconductors NV, iShares …

Diversified Trust Co initiated holding in NXP Semiconductors NV. The purchase prices were between $88.16 and $108.08, with an estimated average …

Memphis, TN, based Investment company Diversified Trust Co (current portfolio) buys iShares Core U.S. Aggregate Bond, NXP Semiconductors NV, iShares Russell 1000 Value, United Breweries Co Inc, Vanguard Growth, sells Vanguard Total Stock Market, eBay Inc, Portman Ridge Finance Corp, SK Telecom Co, Qiagen NV during the 3-months ended 2019Q2, according to the most recent filings of the investment company, Diversified Trust Co. As of 2019Q2, Diversified Trust Co owns 350 stocks with a total value of $1.3 billion. These are the details of the buys and sells.

For the details of Diversified Trust Co’s stock buys and sells,go to https://www.gurufocus.com/guru/diversified+trust+co/current-portfolio/portfolioportfolio

These are the top 5 holdings of Diversified Trust Co

  1. Vanguard FTSE All World Ex US (VEU) – 3,620,012 shares, 13.82% of the total portfolio. Shares reduced by 10.08%
  2. Vanguard S&P 500 (VOO) – 417,519 shares, 8.42% of the total portfolio. Shares added by 2.99%
  3. iShares MSCI EAFE Value (EFV) – 1,707,132 shares, 6.15% of the total portfolio. Shares reduced by 0.42%
  4. iShares Edge MSCI USA Value Factor (VLUE) – 919,006 shares, 5.59% of the total portfolio. Shares added by 3.24%
  5. SPDR S&P 500 (SPY) – 229,992 shares, 5.05% of the total portfolio. Shares reduced by 2.04%

New Purchase: NXP Semiconductors NV (NXPI)

Diversified Trust Co initiated holding in NXP Semiconductors NV. The purchase prices were between $88.16 and $108.08, with an estimated average price of $96.88. The stock is now traded at around $96.99. The impact to a portfolio due to this purchase was 0.14%. The holding were 19,659 shares as of .

New Purchase: United Breweries Co Inc (CCU)

Diversified Trust Co initiated holding in United Breweries Co Inc. The purchase prices were between $26.23 and $29.33, with an estimated average price of $27.49. The stock is now traded at around $29.15. The impact to a portfolio due to this purchase was 0.12%. The holding were 57,432 shares as of .

New Purchase: DuPont de Nemours Inc (6D81)

Diversified Trust Co initiated holding in DuPont de Nemours Inc. The purchase prices were between $58.22 and $146.52, with an estimated average price of $85.68. The stock is now traded at around $61.65. The impact to a portfolio due to this purchase was 0.09%. The holding were 16,080 shares as of .

New Purchase: Sabre Corp (SABR)

Diversified Trust Co initiated holding in Sabre Corp. The purchase prices were between $19.46 and $23.02, with an estimated average price of $21.42. The stock is now traded at around $23.21. The impact to a portfolio due to this purchase was 0.07%. The holding were 41,632 shares as of .

New Purchase: Qudian Inc (QD)

Diversified Trust Co initiated holding in Qudian Inc. The purchase prices were between $5.06 and $8.72, with an estimated average price of $6.89. The stock is now traded at around $8.36. The impact to a portfolio due to this purchase was 0.06%. The holding were 111,529 shares as of .

New Purchase: Portman Ridge Finance Corp (KJ7)

Diversified Trust Co initiated holding in Portman Ridge Finance Corp. The purchase prices were between $2.06 and $3.21, with an estimated average price of $2.48. The stock is now traded at around $2.16. The impact to a portfolio due to this purchase was 0.05%. The holding were 279,554 shares as of .

Added: iShares Core U.S. Aggregate Bond (AGG)

Diversified Trust Co added to a holding in iShares Core U.S. Aggregate Bond by 71.22%. The purchase prices were between $107.29 and $111.16, with an estimated average price of $108.84. The stock is now traded at around $110.79. The impact to a portfolio due to this purchase was 0.18%. The holding were 51,413 shares as of .

Added: iShares Russell 1000 Value (IWD)

Diversified Trust Co added to a holding in iShares Russell 1000 Value by 44.28%. The purchase prices were between $118.9 and $127.38, with an estimated average price of $124.56. The stock is now traded at around $129.68. The impact to a portfolio due to this purchase was 0.14%. The holding were 46,179 shares as of .

Added: Vanguard Growth (VUG)

Diversified Trust Co added to a holding in Vanguard Growth by 436.50%. The purchase prices were between $151.09 and $165.38, with an estimated average price of $160.22. The stock is now traded at around $168.96. The impact to a portfolio due to this purchase was 0.12%. The holding were 12,039 shares as of .

Added: iShares Russell 1000 Growth (IWF)

Diversified Trust Co added to a holding in iShares Russell 1000 Growth by 64.41%. The purchase prices were between $145.76 and $159.39, with an estimated average price of $154.42. The stock is now traded at around $162.98. The impact to a portfolio due to this purchase was 0.12%. The holding were 25,384 shares as of .

Added: Vanguard Value (VTV)

Diversified Trust Co added to a holding in Vanguard Value by 253.29%. The purchase prices were between $104.21 and $111.67, with an estimated average price of $109.16. The stock is now traded at around $113.04. The impact to a portfolio due to this purchase was 0.11%. The holding were 18,979 shares as of .

Added: iShares Core MSCI EAFE (IEFA)

Diversified Trust Co added to a holding in iShares Core MSCI EAFE by 64.31%. The purchase prices were between $58.22 and $61.5, with an estimated average price of $60.25. The stock is now traded at around $61.59. The impact to a portfolio due to this purchase was 0.1%. The holding were 54,386 shares as of .

Sold Out: Qiagen NV (QGEN)

Diversified Trust Co sold out a holding in Qiagen NV. The sale prices were between $35.73 and $41.39, with an estimated average price of $39.04.

Sold Out: Portman Ridge Finance Corp (PTMN)

Diversified Trust Co sold out a holding in Portman Ridge Finance Corp. The sale prices were between $2.25 and $3.75, with an estimated average price of $2.81.

Sold Out: SK Telecom Co Ltd (SKM)

Diversified Trust Co sold out a holding in SK Telecom Co Ltd. The sale prices were between $23.23 and $24.92, with an estimated average price of $24.07.

Sold Out: Red Hat Inc (RHT)

Diversified Trust Co sold out a holding in Red Hat Inc. The sale prices were between $181.94 and $188.25, with an estimated average price of $184.5.

Sold Out: iShares Core Growth Allocation (AOR)

Diversified Trust Co sold out a holding in iShares Core Growth Allocation. The sale prices were between $43.71 and $45.65, with an estimated average price of $44.63.

Sold Out: Navigators Group Inc (NAVG)

Diversified Trust Co sold out a holding in Navigators Group Inc. The sale prices were between $69.8 and $70.01, with an estimated average price of $69.92.

Here is the complete portfolio of Diversified Trust Co. Also check out:

1. Diversified Trust Co’s Undervalued Stocks

2. Diversified Trust Co’s Top Growth Companies, and

3. Diversified Trust Co’s High Yield stocks

4. Stocks that Diversified Trust Co keeps buying

Related Posts:

  • No Related Posts